Pianzaihuang's liver disease medication prices have stopped rising


2025 Annual Report: Revenue down 16.56%, net profit down 27.49%
Shareholders decreased from 283k to 129.9k, northbound holdings dropped from 8.7% to 2.3%.
I find it funny, a few years ago Pianzaihuang was hard to find, scalpers were selling it for hundreds of yuan each, and now?
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin